The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is raging around the world.
Because of its strong spread, variability, survivability, and invisibility, the number of
infected people rise rapidly. On March 11, 2020, the WHO officially declared COVID-19 as a
pandemic disease. As of October 3, 2020, the number of confirmed cases has exceeded 34
million, and the cumulative deaths have exceeded 1 million. There are still no drugs to
treatment the coronavirus disease 2019 (COVID-19). Due to the mutation of virus rapidly,
vaccine development cannot be completed in a short period of time. At the beginning of the
infection outbreak, the governments of China and South Korea, adopted a cooperative of
Chinese and Western medicine to treatment the coronavirus disease 2019 (COVID-19). In
addition to the reported good clinical effects, Chinese medicine prescriptions have included
in diagnosis and treatment guideline of these two countries.

Traditional Chinese medicine is regarded as a dietary supplement in many countries around the
world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected
or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to
help people not to progress to severe illness, and reduce lung damage and mortality. The
investigators gather the effects of people who taking NRICM101 using the Real-World Big Data
Study and the network feedback information collection model. This study can be used as a
reference for global prevention and control of coronavirus disease 2019 (COVID-19).